World's top-performing equities: an investment guide
Score Big with These Goldman Sachs Picks: 11 Must-Have Stocks for Your Portfolio in 2025
As the end of the year approaches and investors start to tinker with their portfolios, the question on everyone's mind is - which stocks are worth investing in for a promising start in the new year?
You're looking for stocks that deliver short-term success and boast long-term growth potential. Lucky for you, Goldman Sachs has done the legwork. Here's the scoop on the impressive group of stocks they've identified.
Goldman Sachs' Superstar Stocks: A Breakdown
Over at "Seeking Alpha," Goldman Sachs has been busy analyzing a selection of quality stocks, handpicked based on strict criteria. Deep Mehta, the Vice President at Goldman Sachs, outlines the chosen stocks as companies boasting these attractive traits:
- Consistent Revenue Growth: A projected steady growth in the mid-single digits for the 2024 to 2026 period.
- Improved Efficiency: The operating result (EBIT) increasing at a faster pace than revenue.
- Positive Net Profit Margins: Steady and continuing to climb.
- Attractive Return on Capital: Solid or rising cash return on invested capital.
These stellar stocks not only excel financially but also offer double-digit upside potential, grabbing investors' attention.
So, which stocks does Goldman Sachs highly recommend for 2025?
•Advanced Micro Devices
•Becton Dickinson & Co.
•BioMarin Pharmaceuticals
•Globant SA
•Informatica
•Intuit
•Lam Research
•Merck & Co.
•Monster Beverage
•Teradyne
•Workday
Take a Peek: Forbes Names the 7 Hidden Gems for 2025
As you weigh your options, remember that Goldman Sachs isn't the only authority offering investment advice. Forbes has also revealed a list of sleeper stocks for 2025, promising impressive gains. Stay tuned as we explore the exciting possibilities!
Investors seeking stocks with short-term success and long-term growth potential might consider Goldman Sachs' picks for 2025, such as Advanced Micro Devices, Becton Dickinson & Co., BioMarin Pharmaceuticals, Globant SA, Informatica, Intuit, Lam Research, Merck & Co., Monster Beverage, Teradyne, and Workday. These stocks are chosen based on consistent revenue growth, improved efficiency, positive net profit margins, and attractive return on capital, offering double-digit upside potential.
Goldman Sachs' Superstar Stocks stand out financially and hold promise for significant returns in 2025, but investors may also want to explore other authorities' recommendations, such as the hidden gems Forbes has identified for the same year.
